OPT
Price
$3.41
Change
+$0.23 (+7.23%)
Updated
Mar 17 closing price
Capitalization
524.82M
88 days until earnings call
PSTV
Price
$0.49
Change
+$0.04 (+8.89%)
Updated
Sep 5 closing price
Capitalization
44.64M
Interact to see
Advertisement

OPT vs PSTV

Header iconOPT vs PSTV Comparison
Open Charts OPT vs PSTVBanner chart's image
Opthea
Price$3.41
Change+$0.23 (+7.23%)
Volume$3.03K
Capitalization524.82M
Plus Therapeutics
Price$0.49
Change+$0.04 (+8.89%)
Volume$5.49M
Capitalization44.64M
OPT vs PSTV Comparison Chart in %
Loading...
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OPT vs. PSTV commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPT is a StrongBuy and PSTV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (OPT: $3.41 vs. PSTV: $0.49)
Brand notoriety: OPT and PSTV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OPT: 100% vs. PSTV: 36%
Market capitalization -- OPT: $524.82M vs. PSTV: $44.64M
OPT [@Biotechnology] is valued at $524.82M. PSTV’s [@Biotechnology] market capitalization is $44.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPT’s FA Score shows that 0 FA rating(s) are green whilePSTV’s FA Score has 0 green FA rating(s).

  • OPT’s FA Score: 0 green, 5 red.
  • PSTV’s FA Score: 0 green, 5 red.
According to our system of comparison, both OPT and PSTV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PSTV’s TA Score shows that 3 TA indicator(s) are bullish.

  • PSTV’s TA Score: 3 bullish, 5 bearish.

Price Growth

OPT (@Biotechnology) experienced а 0.00% price change this week, while PSTV (@Biotechnology) price change was +7.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

OPT is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPT($525M) has a higher market cap than PSTV($44.6M). OPT YTD gains are higher at: -13.176 vs. PSTV (-57.270). PSTV has higher annual earnings (EBITDA): -14.21M vs. OPT (-218.88M). OPT has more cash in the bank: 132M vs. PSTV (6.88M). PSTV has less debt than OPT: PSTV (30K) vs OPT (157M). OPT has higher revenues than PSTV: OPT (87.7K) vs PSTV (0).
OPTPSTVOPT / PSTV
Capitalization525M44.6M1,177%
EBITDA-218.88M-14.21M1,540%
Gain YTD-13.176-57.27023%
P/E RatioN/AN/A-
Revenue87.7K0-
Total Cash132M6.88M1,919%
Total Debt157M30K523,333%
FUNDAMENTALS RATINGS
OPT vs PSTV: Fundamental Ratings
OPT
PSTV
OUTLOOK RATING
1..100
4961
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5665
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PSTV's Valuation (70) in the null industry is in the same range as OPT (94). This means that PSTV’s stock grew similarly to OPT’s over the last 12 months.

PSTV's Profit vs Risk Rating (100) in the null industry is in the same range as OPT (100). This means that PSTV’s stock grew similarly to OPT’s over the last 12 months.

PSTV's SMR Rating (100) in the null industry is in the same range as OPT (100). This means that PSTV’s stock grew similarly to OPT’s over the last 12 months.

OPT's Price Growth Rating (56) in the null industry is in the same range as PSTV (65). This means that OPT’s stock grew similarly to PSTV’s over the last 12 months.

OPT's P/E Growth Rating (100) in the null industry is in the same range as PSTV (100). This means that OPT’s stock grew similarly to PSTV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPTPSTV
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEAAX58.12N/A
N/A
Fidelity Advisor Emerging Asia A
EKJFX15.23N/A
N/A
Allspring Premier Large Co Gr R6
HSZAX5.92N/A
N/A
NexPoint Climate Tech A
PWJAX34.26N/A
N/A
PGIM Jennison International Opps A
LFGFX42.33N/A
N/A
Lord Abbett Focused Growth F

PSTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSTV has been loosely correlated with OPT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTV jumps, then OPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTV
1D Price
Change %
PSTV100%
+9.27%
OPT - PSTV
35%
Loosely correlated
N/A
DRUG - PSTV
33%
Poorly correlated
-3.89%
PBIGF - PSTV
29%
Poorly correlated
N/A
ZYME - PSTV
28%
Poorly correlated
+6.89%
ARRY - PSTV
27%
Poorly correlated
-1.32%
More